RESUMEN
The SIEFED ("Specific Immunological Extraction Followed by Enzymatic Detection") method already developed for the specific detection of the activity of equine myeloperoxidase (MPO) was adapted for the specific measurement of active human MPO in biological fluids or tissue extracts. The method consists of the extraction of MPO from aqueous solutions by immobilized anti-MPO antibodies followed by a washing (to eliminate the extraction medium and the biological fluid with their possible interfering molecules) and the measurement of the activity of MPO with a detection system containing a fluorogenic substrate, H(2)O(2) and nitrite ions as reaction enhancer. The SIEFED was applied to study active MPO in human biological fluids (plasma, bronchoalveolar lavage fluid and supernatant from carotids extracts). The SIEFED for human MPO has a sensitivity limit of 0.080 mU/mL and showed good precision with intra- and inter-assay coefficients of variation below 10 and 20% respectively within a broad range of MPO activities establish from 0.156 to 473 mU/mL. The SIEFED for human MPO will be useful for the specific detection of active MPO in complex fluids and can be complementary to an ELISA to determine an active/total MPO ratio in healthy volunteers and patients especially in case of chronic or acute inflammatory diseases.
Asunto(s)
Líquido del Lavado Bronquioalveolar/química , Pruebas de Enzimas/métodos , Peroxidasa/sangre , Peroxidasa/metabolismo , Estabilidad de Enzimas , Ensayo de Inmunoadsorción Enzimática , Colorantes Fluorescentes , Humanos , Peróxido de Hidrógeno/química , Peróxido de Hidrógeno/metabolismo , Nitritos/química , Nitritos/metabolismo , Peroxidasa/química , Reproducibilidad de los Resultados , TemperaturaRESUMEN
OBJECTIVES: To determine Coll2-1, Coll2-1NO(2) and myeloperoxydase (MPO) levels in serum of patients with knee or hip osteoarthritis (OA) before the surgery, 3 months and 1 year after knee or hip replacement. METHODS: Coll2-1, Coll2-1NO(2) and MPO were measured in 103 patients with isolated symptomatic knee or hip OA candidates for joint replacement. Sera were taken the day before surgery, 3 months and 1 year after hip or knee replacement. Coll2-1 and Coll2-1NO(2) immunohistochemistry was performed on biopsies removed from cartilage lesions. RESULTS: Immunostainings revealed the extensive presence of Coll2-1 and Coll2-1NO(2) in the superficial layer of fibrillated cartilage and around some chondrocytes clusters. Three months after joint replacement, Coll2-1 and MPO serum levels were decreased and even reached the reference value for Coll2-1. By contrast, Coll2-1NO(2) levels remained elevated. At 1-year follow-up, Coll2-1 levels remained at the reference value, MPO levels were similar to those measured at 3 months, and Coll2-1NO(2) levels were unchanged and comparable to the pre-surgery values. However, in patients with pre-surgery values above the median (more than 0.42 nM), Coll2-1NO(2) levels significantly and progressively decreased post-operatively, but tended towards an increase in patients with pre-surgery Coll2-1NO(2) values below the median. CONCLUSIONS: The normalisation of Coll2-1 levels 3 months after surgery indicates that Coll2-1 is a disease-specific marker that is sensitive to the structural changes occurring in a single joint. Furthermore, the immunohistochemical findings are consistent with the concept that the major source of serum Coll2-1 is the damaged articular cartilage. Finally, serum MPO levels decreased after joint replacement indicating that neutrophil activation occurs in OA joints, even in the late stage of the disease.
Asunto(s)
Colágeno Tipo II/metabolismo , Osteoartritis de la Cadera/metabolismo , Osteoartritis de la Rodilla/metabolismo , Fragmentos de Péptidos/metabolismo , Peroxidasa/sangre , Anciano , Anciano de 80 o más Años , Artroplastia de Reemplazo de Cadera , Artroplastia de Reemplazo de Rodilla , Biomarcadores/sangre , Biomarcadores/metabolismo , Cartílago Articular/química , Colágeno Tipo II/sangre , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Osteoartritis de la Cadera/cirugía , Osteoartritis de la Rodilla/cirugía , Fragmentos de Péptidos/sangre , Valores de ReferenciaRESUMEN
A truncated form of SAG1, the immunodominant surface antigen of Toxoplasma gondii, has been produced in the methylotrophic yeast, Pichia pastoris. By construction, the recombinant protein lacks C-terminal residues 308-336 which, in native SAG1, encompass the glycosylphosphatidylinositol anchorage site. Secretion of anchor-less SAG1 proceeded via the yeast prepro alpha-mating factor signal peptide and yielded two immunoreactive protein species having apparent molecular masses of 31.5 and 34.5 kDa, respectively, and differing only by N-glycosylation of the single Asn-X-Ser site present in the molecule. Purification of the anchor-less SAG1 was achieved by a combination of ion-exchange and size-exclusion chromatographies. N-terminal amino acid sequencing of the products indicated the presence of additional residues glutamic acid--alanine at the N-terminal end of the products. Despite incomplete processing and unnatural glycosylation, anchor-less SAG1 proteins apparently adopted a suitable conformation recognized by monoclonal and human serum-derived antibodies, specific for the native SAG1. In addition, the recombinant anchor-less SAG1 proved competent for inducing proliferation, in vitro, of mononuclear cells from seropositive individuals. Finally, properly adjuvanted anchor-less SAG1 was able to induce protection of mice against a lethal challenge with T. gondii tachyzoites.
Asunto(s)
Pichia/genética , Proteínas Protozoarias/inmunología , Proteínas Protozoarias/aislamiento & purificación , Toxoplasma/inmunología , Secuencia de Aminoácidos , Animales , Antígenos de Protozoos/genética , Antígenos de Protozoos/inmunología , Antígenos de Protozoos/aislamiento & purificación , Antígenos de Protozoos/farmacología , División Celular/efectos de los fármacos , Ensayo de Inmunoadsorción Enzimática , Femenino , Humanos , Leucocitos Mononucleares/efectos de los fármacos , Ratones , Ratones Endogámicos BALB C , Datos de Secuencia Molecular , Pichia/química , Ingeniería de Proteínas/métodos , Pliegue de Proteína , Proteínas Protozoarias/genética , Proteínas Protozoarias/farmacología , Conejos , Tasa de Supervivencia , Células TH1/inmunología , Toxoplasmosis/diagnóstico , Toxoplasmosis/tratamiento farmacológico , Toxoplasmosis/inmunología , Toxoplasmosis Animal/inmunología , Toxoplasmosis Animal/mortalidad , Toxoplasmosis Animal/parasitología , Transformación GenéticaRESUMEN
The purpose of this study was to compare the antibody responses to varicella-zoster virus (VZV) gE and gB after natural VZV infection and after vaccination with live attenuated OKA vaccine in order to determine the relative importance of these proteins as components of a subunit vaccine. Anti-VZV antibody titers determined by IFA were of the same order of magnitude in sera from individuals with a history of varicella and in vaccinated children but higher in individuals given booster vaccination. The titers of anti-gE and anti-gB antibodies were measured by ELISA using recombinant gE or gB as capture antigen. From these experiments, it appears that the ratio of anti-gE to anti-gB antibody is highly variable from one individual to another but relatively stable over a long period of time for a particular individual, even after a zoster episode. Neutralizing antibodies directed against gE or gB were also measured by subtracting the neutralization titers obtained before and after depletion of the specific antibodies on immobilized recombinant gE, gB, or both. This showed that, with respect to neutralization, anti-gE and anti-gB are equally prevalent in vaccinated children and that anti-gE is generally, but not always, predominant over anti-gB in VZV-infected individuals. Finally, antibodies to these two glycoproteins appear to be predominant among the neutralizing antibodies directed to other VZV antigens.
Asunto(s)
Anticuerpos Antivirales/sangre , Vacuna contra la Varicela/inmunología , Varicela/inmunología , Herpesvirus Humano 3/inmunología , Proteínas del Envoltorio Viral/inmunología , Adulto , Anciano , Anticuerpos Antivirales/aislamiento & purificación , Antígenos Virales , Niño , Preescolar , Herpes Zóster/inmunología , Humanos , Lactante , Persona de Mediana Edad , Pruebas de NeutralizaciónRESUMEN
Human follicular dendritic cell (FDC)-like cells (FLC) have been utilized for the in vitro analysis of germinal center reactions. However, there is no consensus whether FLC represent FDC in vitro. The purpose of the present study has therefore been to determine distinguishing features of FDC and FLC in vitro. The expression of CD40, CD54, CD49d, cytokine (gamma-IFN and IL-4)-dependent MHC-class II, and CD106 was observed to be specific for the determination of FDC in long-term culture. The cytokine-dependent emperipolesis of germinal center B cells was establised as another discriminating property for FDC in vitro. In 2 out of 72 long-term cultures of FDC, we encountered dividing cells among the non-dividing population of FDC. The dividing cells expressed accessory molecules similar to those of FDC but showed emperipolesis only for the initial few days of their growth. FDC did not enhance the CD40-dependent proliferation of germinal center B cells; in contrast, FLC augumented it. Both types of cells produced a significant amount of cytokine-dependent IL-6. Further studies are needed to determine whether FLC originate from FDC in vitro.
Asunto(s)
Citocinas/farmacología , Células Dendríticas/fisiología , Centro Germinal/efectos de los fármacos , Linfocitos/efectos de los fármacos , Adhesión Celular/fisiología , División Celular/efectos de los fármacos , Células Cultivadas , Centro Germinal/citología , Humanos , Inmunofenotipificación , Interleucina-6/biosíntesis , Linfocitos/citología , Proteínas Recombinantes/farmacologíaRESUMEN
Follicular dendritic cells (FDC) are unique non-lymphoid cells found only in lymph follicles. They play a part in the survival, proliferation and differentiation of B cells. To analyse the influence of FDC on B-lymphocyte proliferation, we isolated them from human tonsils on albumin gradients and treated them with mitomycin C to prevent the multiplication of lymphoid cells harboured in their cytoplasmic evaginations. FDC cultured for 12-16 h remained attached to the substrate; non-adherent cells were carefully eliminated by washing. Purified B cells cultured alone or with contaminant-cleared FDC were maintained for 2 days in the presence or absence of various stimulants, after which tritiated thymidine uptake by these cells was measured. In the absence of activators, FDC did not induce B-cell multiplication. B cells cultured in the presence of FDC exhibited increased 3H-TdR uptake when activated with anti-CD40 MoAb, anti-immunoglobulin MoAb or transferrin, but not when stimulated with Staphylococcus aureus strain Cowan I (SAC) at a given concentration. In the latter case, B-cell proliferation clearly decreased. In control cocultures where mitomycin-C-treated non-adherent cells were used instead of FDC in the presence of the different stimulants, no increase in B-cell proliferation was observed. The results suggest that, inside the germinal centres, FDC modulation of B-cell proliferation depends on the activation state of the B cells and on the stimulant encountered.
Asunto(s)
Linfocitos B/inmunología , Células Dendríticas/inmunología , Activación de Linfocitos , Mitógenos/farmacología , Antibióticos Antineoplásicos/farmacología , Anticuerpos Monoclonales/farmacología , Antígenos CD40/inmunología , División Celular , Separación Celular , Células Cultivadas , Niño , Preescolar , Replicación del ADN , Humanos , Inmunoglobulina G/inmunología , Activación de Linfocitos/efectos de los fármacos , Mitomicina/farmacología , Tonsila Palatina/citología , Staphylococcus aureus/inmunología , Transferrina/inmunologíaAsunto(s)
Tonsila Palatina/citología , Linfocitos T/citología , Linfocitos B/inmunología , Antígenos CD57/metabolismo , Comunicación Celular , División Celular , Células Dendríticas/inmunología , Fibroblastos/inmunología , Humanos , Técnicas In Vitro , Activación de Linfocitos , Tonsila Palatina/inmunología , Linfocitos T/inmunologíaAsunto(s)
Linfocitos B/citología , Linfocitos B/inmunología , Células Dendríticas/inmunología , Tejido Linfoide/citología , Tejido Linfoide/inmunología , Animales , Antígenos CD40/metabolismo , Comunicación Celular , División Celular , Humanos , Técnicas In Vitro , Activación de Linfocitos , Ratones , Staphylococcus aureus/inmunologíaAsunto(s)
Células Dendríticas/inmunología , Centro Germinal/inmunología , Presentación de Antígeno , Quimiotaxis de Leucocito , Centro Germinal/citología , Tolerancia Inmunológica , Cambio de Clase de Inmunoglobulina , Memoria Inmunológica , Activación de Linfocitos , Linfocitos/inmunología , Modelos InmunológicosRESUMEN
We have isolated two subtypes of helper T cells from human tonsils: CD4+CD57+ cells, mostly located in the germinal center (GC), and CD4+CD57- cells, distributed through the interfollicular areas but also present in the GC. In a functional study, we have compared the capacities of these T-cell subtypes to stimulate B cells in cocultures. In order to block T-cell proliferation while maintaining their activation level, we pretreated isolated T cells with mitomycin C prior to culture in the presence of B cells and added polyclonal activators such as PHA and Con A, combined or not with IL-2. Contrary to CD4+ CD57- cells, CD4+CD57+ cells did not markedly enhance B-cell proliferation. Even when sIgD.B cells typical of germinal center cells were tested, the CD4+CD57+ cells had no significant effect. This is in accordance with the location of these cells: They mainly occupy the light zones of the GC where few B cells divide. Even when added to preactivated, actively proliferating cells, CD4+CD57 cells failed to modulate B-cell multiplication. On the supernatants of B-cell-T-cell cocultures, we examined by the ELISA technique the effect of T cells on Ig synthesis. Contrary to CD57+ T cells, whose effect was strong, CD57- T cells weakly stimulated Ig synthesis. More IgM than IgG was generally found. Because CD57 antigen is a typical marker of natural killer cells, we tested the cytolytic activity of tonsillar CD4+CD57+ cells on K562 target cells. Unlike NK cells, neither CD4+CD57+ nor CD4+CD57- cells exhibit any cytotoxicity. Thus, germinal center CD4+CD57+ cells are not cytolytic and do not strongly stimulate either B-cell proliferation or Ig secretion. CD4+CD57- cells, however, enhance B-cell proliferation and differentiation, thus acting like the classical helper cells of the T-dependent areas.
Asunto(s)
Linfocitos B/inmunología , Linfocitos T CD4-Positivos/inmunología , Tonsila Palatina/citología , Tonsila Palatina/inmunología , Subgrupos de Linfocitos T/inmunología , Linfocitos T Colaboradores-Inductores/inmunología , Antígenos CD4/metabolismo , Linfocitos T CD4-Positivos/citología , Antígenos CD57/metabolismo , Citotoxicidad Inmunológica , Humanos , Inmunoglobulinas/biosíntesis , Técnicas In Vitro , Activación de Linfocitos , Cooperación Linfocítica , Subgrupos de Linfocitos T/citología , Linfocitos T Colaboradores-Inductores/citología , Células Tumorales CultivadasRESUMEN
Follicular dendritic cells (FDC) are only located within follicles of secondary lymphoid tissues. The origin of this peculiar cell type is not clearly defined. To contribute to this study, we applied two monoclonal antibodies (MAS516 and 5B5) considered as specific for fibroblasts to tonsil cryosections and to isolated follicular dendritic cells. On the basis of an enzyme cocktail digestion of human tonsils and a fractionation procedure on albumin gradients, FDC can be prepared in the form of cell aggregates with associated lymphoid cells. MAS516 reacts with surface membrane molecules expressed by human fibroblasts, tissue macrophages and peripheral blood monocytes. With immunoperoxidase assays on tonsil cryosections connective tissue cells and macrophages are stained. Inside germinal centres, heavy labelling of the light zone was found. The MAS516 staining pattern is very similar to that of specific FDC markers DRC-1 or BU10. All isolated FDC reacted with MAS516 antibody. 5B5, considered as a typical fibroblast marker, reacts with human prolyl-4-hydroxylase which is an intracellular enzyme related to collagen biosynthesis. In cryosections, interfollicular and capsular areas showed 5B5 positive connective tissue fibroblasts. In germinal centres, some cells presenting features of FDC were 5B5 positive. After cell separation, 25%-50% of the isolated FDC were labelled with this antibody. This positivity of some FDC for 5B5 antibody may support the idea of their fibroblastic origin. The combination of observations realized in situ and after cell purification ensured an unequivocal recognition and identification of FDC.(ABSTRACT TRUNCATED AT 250 WORDS)
Asunto(s)
Anticuerpos Monoclonales/análisis , Células Dendríticas/química , Fibroblastos/inmunología , Tonsila Palatina/química , Antígenos de Superficie/inmunología , Biomarcadores , Niño , Preescolar , Humanos , Técnicas para Inmunoenzimas , Tonsila Palatina/citología , Procolágeno-Prolina Dioxigenasa/inmunologíaRESUMEN
At the recent Germinal Centre Conference in Spa*, over 200 immunologists gathered to study the fate of lymph follicles, B- and T-cell selection, cell migration, accessory cells, and pathological conditions such as lymphoproliferative diseases and AIDS. Here, Ernst Heinen and Alain Bosseloir report on this fascinating field.
Asunto(s)
Células Dendríticas/clasificación , Animales , Células de la Médula Ósea , Humanos , Mesodermo/citologíaAsunto(s)
Antígenos de Superficie/fisiología , Linfocitos B/inmunología , Células Dendríticas/inmunología , Leucocitos Mononucleares/inmunología , Proteínas de la Membrana/inmunología , Anticuerpos Antiidiotipos/farmacología , Anticuerpos Monoclonales/inmunología , Antígenos CD/inmunología , Antígenos de Diferenciación de Linfocitos B/inmunología , Antígenos de Superficie/biosíntesis , Antígenos de Superficie/genética , Linfocitos B/metabolismo , Células Sanguíneas , Antígenos CD40 , Células Cultivadas , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Inmunofenotipificación , Interleucina-10/farmacología , Interleucina-4/farmacología , Leucocitos Mononucleares/metabolismo , Activación de Linfocitos , Subgrupos Linfocitarios/inmunología , Subgrupos Linfocitarios/metabolismo , Tonsila Palatina/citología , Proteínas Recombinantes/farmacología , Acetato de Tetradecanoilforbol/farmacologíaRESUMEN
The presence of CD4+, CD57+ T cells in the germinal centers has been reported by several authors. The CD57 antigen is also expressed by natural killer (NK) cells. We purified CD57+ cells from human tonsils and blood by microdissection, rosetting with sheep red blood cells and magnetic cell sorting (MACS) and examined the ultrastructural morphology of these cells. Clear differences were found in cell aspect: blood NK contained large granules which were not found in the tonsillar CD57+ cells. These latter appeared medium-sized and not fully activated. After immunolabeling, the tonsillar CD57+ cells were mainly found in the light zone of the germinal centers.
Asunto(s)
Antígenos CD , Antígenos de Diferenciación de Linfocitos T , Tonsila Palatina/ultraestructura , Subgrupos de Linfocitos T/ultraestructura , Anticuerpos Monoclonales/inmunología , Antígenos CD/inmunología , Antígenos de Diferenciación de Linfocitos T/inmunología , Antígenos CD57 , Separación Celular , Niño , Humanos , Técnicas de Inmunoadsorción , Células Asesinas Naturales/ultraestructura , Leucocitos Mononucleares/ultraestructura , Magnetismo , Microesferas , Formación de RosetaAsunto(s)
Anticuerpos Monoclonales/inmunología , Antígenos de Superficie/análisis , Linfocitos B/química , Células Dendríticas/química , Tejido Linfoide/química , Células Madre Neoplásicas/química , Antígenos CD/análisis , Antígenos CD19 , Antígenos de Diferenciación de Linfocitos B/análisis , Antígenos de Superficie/fisiología , Linfocitos B/patología , Células Sanguíneas/química , Complejo CD3/análisis , Adhesión Celular , Células Dendríticas/patología , Citometría de Flujo , Humanos , Inmunofenotipificación , Leucemia Linfocítica Crónica de Células B/patología , Leucemia Prolinfocítica/patología , Tejido Linfoide/patología , Células Madre Neoplásicas/patología , Neprilisina/análisis , Especificidad de Órganos , Tonsila Palatina/química , Tonsila Palatina/citología , Leucemia-Linfoma Linfoblástico de Células Precursoras/patologíaAsunto(s)
Células Dendríticas/metabolismo , Receptores de Superficie Celular , Factor de Necrosis Tumoral alfa , División Celular/efectos de los fármacos , Células Cultivadas , ADN/genética , Sondas de ADN , Células Dendríticas/efectos de los fármacos , Expresión Génica , Humanos , Hibridación in Situ , Tonsila Palatina/química , Tonsila Palatina/citología , Sondas ARN , ARN Mensajero/análisis , Receptores de Superficie Celular/análisis , Receptores del Factor de Necrosis Tumoral , Factor de Necrosis Tumoral alfa/genética , Factor de Necrosis Tumoral alfa/farmacologíaRESUMEN
We have investigated which areas produce interleukin 6 (IL 6) in human tonsils. This growth factor is required for the terminal differentiation of B lymphocytes into plasmocytes. Using 35S-labeled IL 6 cDNA we demonstrated IL 6 gene expression over various areas of the tonsils, with consistent exception of the follicles, by in situ hybridization. It is, therefore, proposed that B cells are stimulated during their migration out of the follicles.